Harmonization of interpretative comments in laboratory hematology reporting: The recommendations of the Working Group on Diagnostic Hematology of the Italian Society of Clinical Chemistry and Clinical Molecular Biology (WGDH-SIBioC)

Clinical Chemistry and Laboratory Medicine

Volumn 57, Issue 1, 2019, Pages 66-77

  Buoro, Sabrina ^a   Da Rin, Giorgio ^b   Fanelli, Alessandra ^c   Lippi, Giuseppe ^d  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^b San Bassiano Hospital   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Continuing professional development; Harmonization; Hematology; Interpretative commenting; Morphology; Platelets; Postanalytical quality; Red blood cells (RBC); Standardization; White blood cells (WBC)

Indexed keywords

BLAST CELL; BLOOD CELL; BLOOD SMEAR; BONE MARROW CELL; CANCER CLASSIFICATION; CELL STRUCTURE; CLINICAL LABORATORY; CLINICAL OUTCOME; ERYTHROCYTE; HEALTH CARE QUALITY; HEMATOLOGIC MALIGNANCY; HEMATOLOGY; HUMAN; ITALY; LABORATORY TEST; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOID CELL; MEDICAL INFORMATION; MEDICAL TERMINOLOGY; MICROSCOPY; NUCLEATED RED BLOOD CELL; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETICULOCYTE; REVIEW; STANDARDIZATION; THROMBOCYTE; WORLD HEALTH ORGANIZATION; BLOOD EXAMINATION; MEDICAL SOCIETY; MOLECULAR BIOLOGY; NOMENCLATURE; STANDARD;

HEMATOLOGIC TESTS; HUMANS; ITALY; MOLECULAR BIOLOGY; REFERENCE STANDARDS; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC;

EID: 85041680149     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2017-0972     Document Type: Review

References (55)

1. Aarsand AK, Sandberg S. How to achieve harmonisation of laboratory testing-The complete picture. Clin Chim Acta 2014;432:8-14.
2. Tate JR, Johnson R, Barth J, Panteghini M. Harmonization of laboratory testing-current achievements and future strategies. Clin Chim Acta 2014;432:4-7.
3. Plebani M, Panteghini M. Promoting clinical and laboratory interaction by harmonization. Clin Chim Acta 2014;432:15-21.
4. Marques MB, Anastasi J, Ashwood E, Baron B, Fitzgerald R, Fung M, et al. The clinical pathologist as consultant. Am J Clin Pathol 2011;135:11-2.
5. Vasikaran S, Sikaris K, Kilpatrick E, French J, Badrick T, Osypiw J, et al. Assuring the quality of interpretative comments in clinical chemistry. Clin Chem Lab Med 2016;54:1901-11.
6. Tate JR, Myers GL. Harmonization of clinical laboratory test results. EJIFCC 2016;27:5-14.
7. Lecompte TP, Bernimoulin MP. Novel parameters in blood cell counters. Clin Lab Med 2015;35:209-24.
8. Bain B. Diagnosis from the blood smear. N Engl J Med 2005;353:498-507.
9. Zini G, Bain B, Bettelheim P, Cortez J, D'Onofrio G, Faber E, et al. A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European leukemia network WP10, on behalf of the ELN morphology faculty. Br J Haematol 2010;151:359-64.
10. Palmer L, Briggs C, McFadden S, Zini G, Burthem J, Rozenberg G, et al. ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features. Int J Lab Hem 2015;37:287-303.
11. Buoro S, Apassiti Esposito S, Balboni F, Da Rin G, Di Fabio A, Fanelli A, et al. Stato dell'arte della diagnostica ematologica nei servizi di Medicina di Laboratorio in Italia. Biochim Clin 2015;39:25-40.
12. La Gioia A, Balboni F, Buoro B, Fanelli A, Gioia M, Marini A, et al. Gruppo di Studio SIBioC-Medicina di Laboratorio Diagnostica Ematologica. Interpretative comments in the laboratory hematology report [I commenti interpretativi nel referto ematologico di laboratorio]. Biochim Clin 2016;40:255-69.
13. Trimoreau F, Galoisy AC, Genevieve F, Bardet V, Cornet E, Hurst JP, et al. Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC). J Clin Pathol 2017;70:395-402.
14. Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 2011;128:305-10.
15. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th ed. Lyon: IARC, 2008.
16. Johansson U, Bloxham D, Couzens S, Jesson J, Morilla R, Erber W, et al. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. Br J Haematol 2014;165:455-88.
17. Carayon P, Hundt AS, Karsh BT, Gurses AP, Alvarado CJ, Smith M, et al. Work system design for patient safety: the SEIPS model. Qual Saf Health Care 2006;15:50-8.
18. Carayon P, Wetterneck TB, Rivera-Rodriguez AJ, Hundt AS, Hoonakker P, Holden R, et al. Human factors systems approach to healthcare quality and patient safety. Appl Ergon 2014;45:14-25.
19. Keng TB, De La Salle B, Bourner G, Merino A, Han JY, Kawai Y, et al. Standardization of haematology critical results management in adults: an International Council for Standardization in Haematology, ICSH, survey and recommendations. Int J Lab Hematol 2016;38:457-71.
20. Chabot-Richards DS, George TI. Leukocytosis. Int J Lab Hematol 2014;36:279-88.
21. George TI. Malignant or benign leukocytosis. Hematology Am Soc Hematol Educ Program 2012;2012:475-84.
22. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375-90.
23. D'Onofrio G, Zini G. Morfologia delle malattie del sangue, 1st ed. Roma: Verduci Editore, 2013.
24. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391-405.
25. Danise P, Maconi M, Barrella F, Di Palma A, Avino D, Rovetti A, et al. Evaluation of nucleated red blood cells in the peripheral blood of hematological diseases. Clin Chem Lab Med 2011;25:50:357-60.
26. Barnes PW, McFadden SL, Machin SJ, Simson E. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. Lab Hematol 2005;11:83-90.
27. Jones G, Parry-Jones N, Wilkins B, Else M, Catovsky D; British Committee for Standards in Haematology. Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant. Br J Haematol 2011;156:186-95.
28. Naderi N, Yang DT. Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia. Arch Pathol Lab Med 2013;137:580-5.
29. Ravinet A, Bay JO, Toumillhac O. Plasma cell leukemia. Bull Cancer 2014;101:1048-58.
30. Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespi MT, Tomonaga M, et al. Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 2014;38:447-53.
31. Mufti GM, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008;93:1712-7.
32. Goasguen JE, Bennet JM, Bain BJ, Vallespi T, Brunning R, Mufti, GJ, et al. Morphological evaluation of monocytes and their precursors. Haematologica 2009;94:994-7.
33. Constantino BT. Reporting and grading of abnormal red blood cell morphology. Int J Lab Hematol 2015;37:1-7.
34. Berentsen S, Sundic T. Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy. BioMed Res Int 2015;2015:1-11.
35. Zini G, d'Onofrio G, Briggs C, Erber W, Jou JM, Lee SH, et al. ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol 2012;34:107-16.
36. Moreno A, Menke D. Assessment of platelet numbers and morphology in the peripheral blood smear. Clin Lab Med 2002;22:193-213.
37. Latger-Cannard V, Fenneteau O, Salignac S, Lecompte TP, Schlegel N. Platelet morphology analysis. Methods Mol Biol 2013;992:207-25.
38. Sivapalaratnam S, Collins J, Gomez K. Diagnosis of inherited bleeding disorders in the genomic era. Br J Haematol 2017;14:1-5.
39. Nagler M, Keller P, Siegrist D, Alberio L. A case of EDTAdependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon. BMC Clin Pathol 2014;14:19.
40. Valent P, Sotlar K, Blatt K, Hartmann K, Reiter A, Sadovnik I, et al. Proposed diagnostic criteria and classification of basophilic leukemias and related disorders [review]. Leukemia 2017;31:788-97.
41. Dalal BI, Brigden ML. Artifacts that may be present on a blood film. Clin Lab Med 2002;22:81-100.
42. Ford J. Red blood cell morphology. Int J Lab Hematol 2013;35:351-7.
43. Clinical Laboratory Standards Institute. Reference leukocyte (WBC) differential count (proportional) and evaluation of instrumental Methods; approved guideline-second edition. CLSI document H20-A2. Wayne, PA: Clinical Laboratory Standards Institute, 2010.
44. Committee on Diagnostic Error in Health Care; Board on Health Care Services; Institute of Medicine; The National Academies of Sciences, Engineering, and Medicine; Balogh EP, Miller BT, Ball JR, editors. Improving Diagnosis in Health Care. Washington (DC): National Academies Press (US), 2015. Available at: https:// www.ncbi.nlm.nih.gov/books/NBK338596/doi:10.17226/2179. Accessed: 28 Sept 2017.
45. Khoder A, Al Obaidi M, Wiles N, Nadal-Melsio E, Bain BJ. Lymphoplasmacytoid cytology in plasma cell leukemia. Am J Hematol 2017. doi:10.1002/ajh.24940.
46. Tan GC, Stalling M, Dennis G, Nunez M, Kahwash, SB. Pseudothrombocytopenia due to platelet clumping: a case report and brief review of the literature. Case Rep Hematol 2016;2016:1-4.
47. Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? Int J Lab Hematol 2016;38:123-32.
48. Zandecki M, Genevieve F, Gerard J, Godon A. Spurious counts and spurious results on haematology analysers: a review. Part II: white blood cells, red blood cells, haemoglobin, red cell indices and reticulocytes. Int J Lab Hematol 2007;29:21-41.
49. Zandecki M, Genevieve F, Gerard J, Godon A. Spurious counts and spurious results on haematology analysers: a review. Part I: platelets. Int J Lab Hematol 2007;29:4-20.
50. ISO 15189. Medical laboratories-requirements for quality and competence. Geneva, Switzerland: International Organization for Standardization, 2012.
51. Buttarello M, Plebani M. Automated blood cell counts: state of the art. Am J Clin Pathol 2008;130:104-16.
52. Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol 2009;3:277-97.
53. Lippi G, Plebani M. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med 2012;50:1281-5.
54. Vinholt PJ, Hvas A-M, Nybo M. An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients. Eur J Haematol 2014;92:367-76.
55. Briggs C, Harrison P, Machin SJ. Continuing developments with the automated platelet count. Int J Lab Hematol 2007;29:77-91.